Volitionrx (VNRX) Net Income towards Common Stockholders Growth (1y) (2013 - 2025)
Volitionrx (VNRX) Net Income towards Common Stockholders Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 121.14% |
| 10 | Volitionrx | 89,525.10 | -1.03 Mn | - | 104.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 104.50% |
| Sep 30, 2025 | 99.46% |
| Jun 30, 2025 | 100.43% |
| Mar 31, 2025 | 29.06% |
| Dec 31, 2024 | 33.40% |
| Sep 30, 2024 | 30.45% |
| Jun 30, 2024 | 26.24% |
| Mar 31, 2024 | 4.69% |
| Dec 31, 2023 | -20.11% |
| Sep 30, 2023 | -8.10% |
| Jun 30, 2023 | -11,607.59% |
| Mar 31, 2023 | -10,554.71% |
| Dec 31, 2022 | 9.87% |
| Sep 30, 2022 | -8.50% |
| Jun 30, 2022 | 73.13% |
| Mar 31, 2022 | 791.10% |
| Dec 31, 2021 | -33,885.22% |
| Sep 30, 2021 | -88,751.34% |
| Jun 30, 2021 | 722.62% |
| Mar 31, 2021 | 100.16% |